March 2023
192 articles-
Mar 29 · 00:21Bio Business News
Cullinan sets sail toward US with novel bispecific from Harbour BioMed for $25M in cash
-
Mar 28 · 03:02Biotechnology Daily
Peanut allergy drug staves off anaphylaxis for 2 weeks with a single dose
-
Mar 28 · 03:01Biotechnology Daily
Philips CPAP recall spurs another 82 reports of patient deaths, pushing total to 346
-
Mar 28 · 03:00Biotechnology Daily
Frequency falters after phase 2 fail, axing 2 assets and 55% of staff
-
Mar 28 · 02:58Biotechnology Daily
Ena slices data to claim flu success in phase 2 and nasal spray's wide-ranging potential
-
Mar 28 · 02:57Bio Business News
Alcon reaches $199M settlement with J&J Vision over cataract surgery lasers
-
Mar 28 · 02:56Bio Business News
Insulet bulks up automated insulin delivery tech with $25M purchase of Bigfoot patents
-
Mar 28 · 02:55Bio Business News
3 years after rejecting $1B buyout, Sorrento files for bankruptcy amid legal battles
-
Mar 28 · 02:54Bio Business News
On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
-
Mar 27 · 03:25Biotechnology Daily
Titan Medical lays off 70% of staff as search for buyer comes up short
-
Mar 27 · 03:24Biotechnology Daily
Faced with safety issues over inflammation drug, AstraZeneca spinout Aristea closes shop
-
Mar 27 · 03:22Biotechnology Daily
Blueprint told to stop sketching as FDA slaps partial hold on phase 1/2 trial
-
Mar 27 · 03:21Biotechnology Daily
Valproic acid, an old seizure drug, sees new potential in preserving donor hearts
-
Mar 27 · 03:19Bio Business News
NuVasive, Globus Medical ink $3.1B orthopedic device merger, sending investors scrambling
-
Mar 27 · 03:18Bio Business News
Baxter begins layoffs of 'less than 5%' of workforce after posting $2.4B net loss in 2022
-
Mar 27 · 03:17Bio Business News
Medtronic fined $106M in trial over TAVR device patent infringement
-
Mar 27 · 03:16Bio Business News
Mineralys, amid signs of thawing IPO market, upsizes offering to raise $192M for race with AstraZeneca
-
Mar 27 · 01:19Market Watch
Okasan Securities Group Shares Indicated 20% Higher After Buyback Plan
-
Mar 27 · 01:17Market Watch
Sinopec's 2022 Net Profit Fell 6.9% as Domestic Demand Waned
-
Mar 24 · 04:07Biotechnology Daily
Eliem drops depression drug, ending pursuit of Biogen-Sage and laying off 55% of team
-
Mar 24 · 04:06Biotechnology Daily
'Expect us to act' on M&A, AbbVie CEO says as company plots post-Humira plans
-
Mar 24 · 04:05Biotechnology Daily
Despite rapidly emptying pipeline, AstraZeneca stays loyal to vaccine, immune therapy business
-
Mar 24 · 04:04Biotechnology Daily
GE HealthCare snaps up ultrasound AI maker Caption Health
-
Mar 24 · 04:03Bio Business News
Abbott offers $890M for artery-cleaning device maker Cardiovascular Systems